<s id="wsj_2089.1"> 43
1 	 0 	 N/N 	 1 	 AG Sandoz
1 	 11 	 (S[dcl]\NP)/S[em] 	 1 	 AG said
9 	 3 	 NP[nb]/N 	 1 	 group a
9 	 4 	 N/N 	 1 	 group major
9 	 5 	 N/N 	 1 	 group Swiss
9 	 6 	 N/N 	 1 	 group chemical <XU>
9 	 8 	 N/N 	 1 	 group pharmaceutical
9 	 11 	 (S[dcl]\NP)/S[em] 	 1 	 group said
12 	 11 	 (S[dcl]\NP)/S[em] 	 2 	 that said
15 	 13 	 NP[nb]/N 	 1 	 sales its
15 	 14 	 N/N 	 1 	 sales group
15 	 16 	 S[dcl]\NP 	 1 	 sales rose
16 	 12 	 S[em]/S[dcl] 	 1 	 rose that
16 	 18 	 (S\NP)\(S\NP) 	 2 	 rose %
16 	 19 	 ((S\NP)\(S\NP))/NP 	 2 	 rose to
16 	 28 	 ((S\NP)\(S\NP))/NP 	 2 	 rose in
16 	 37 	 ((S\NP)\(S\NP))/NP 	 2 	 rose with
18 	 17 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 % 25
21 	 20 	 (N/N)/(N/N) 	 2 	 billion 9.482
22 	 19 	 ((S\NP)\(S\NP))/NP 	 3 	 francs to
22 	 21 	 N/N 	 1 	 francs billion
22 	 23 	 (NP\NP)/NP 	 1 	 francs -LRB-
24 	 23 	 (NP\NP)/NP 	 2 	 $ -LRB-
26 	 24 	 N/N[num] 	 1 	 billion $
26 	 25 	 N/N 	 1 	 billion 5.80
32 	 28 	 ((S\NP)\(S\NP))/NP 	 3 	 months in
32 	 29 	 NP[nb]/N 	 1 	 months the
32 	 30 	 N/N 	 1 	 months first
32 	 31 	 N/N 	 1 	 months nine
32 	 33 	 (NP\NP)/NP 	 1 	 months of
35 	 33 	 (NP\NP)/NP 	 2 	 year of
35 	 34 	 NP[nb]/N 	 1 	 year this
39 	 37 	 ((S\NP)\(S\NP))/NP 	 3 	 gains with
39 	 38 	 N/N 	 1 	 gains strong
39 	 40 	 (NP\NP)/NP 	 1 	 gains in
42 	 40 	 (NP\NP)/NP 	 2 	 divisions in
42 	 41 	 NP[nb]/N 	 1 	 divisions all
<\s>
<s id="wsj_2089.2"> 8
1 	 0 	 NP[nb]/N 	 1 	 year A
1 	 2 	 (S/S)\NP 	 2 	 year earlier
3 	 4 	 (S[dcl]\NP)/NP 	 1 	 sales totaled
4 	 2 	 (S/S)\NP 	 1 	 totaled earlier
6 	 5 	 (N/N)/(N/N) 	 2 	 billion 7.567
7 	 4 	 (S[dcl]\NP)/NP 	 2 	 francs totaled
7 	 6 	 N/N 	 1 	 francs billion
<\s>
<s id="wsj_2089.3"> 33
2 	 0 	 N/N 	 1 	 rates Positive
2 	 1 	 N/N 	 1 	 rates currency
2 	 7 	 (S[dcl]\NP)/PP 	 1 	 rates led
6 	 4 	 N/N 	 1 	 growth strong
6 	 5 	 N/N 	 1 	 growth sales
6 	 7 	 (S[dcl]\NP)/PP 	 1 	 growth led
7 	 15 	 ((S\NP)\(S\NP))/NP 	 2 	 led in
7 	 19 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 led although
8 	 7 	 (S[dcl]\NP)/PP 	 2 	 to led
11 	 8 	 PP/NP 	 1 	 rise to
11 	 9 	 NP[nb]/N 	 1 	 rise a
11 	 10 	 N/N 	 1 	 rise substantial
11 	 12 	 (NP\NP)/NP 	 1 	 rise in
14 	 12 	 (NP\NP)/NP 	 2 	 profit in
14 	 13 	 N/N 	 1 	 profit consolidated
17 	 15 	 ((S\NP)\(S\NP))/NP 	 3 	 period in
17 	 16 	 NP[nb]/N 	 1 	 period the
21 	 20 	 NP[nb]/N 	 1 	 company the
21 	 22 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 company did
21 	 24 	 (S[b]\NP)/NP 	 1 	 company provide <XB>
21 	 28 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 company is <XB>
21 	 29 	 S[adj]\NP 	 1 	 company customary <XB>
22 	 19 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 did although
22 	 23 	 (S\NP)\(S\NP) 	 2 	 did n't
24 	 22 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 provide did
24 	 27 	 ((S\NP)\(S\NP))/(S[dcl]\NP) 	 2 	 provide as
25 	 24 	 (S[b]\NP)/NP 	 2 	 figures provide
28 	 27 	 ((S\NP)\(S\NP))/(S[dcl]\NP) 	 3 	 is as
28 	 30 	 ((S\NP)\(S\NP))/NP 	 2 	 is with
29 	 28 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 customary is
32 	 30 	 ((S\NP)\(S\NP))/NP 	 3 	 companies with
32 	 31 	 N/N 	 1 	 companies Swiss
<\s>
<s id="wsj_2089.4"> 20
0 	 1 	 (S[dcl]\NP)/S[dcl] 	 1 	 Sandoz said
2 	 3 	 ((S[dcl]\NP)/(S[ng]\NP))/NP 	 1 	 it expects
3 	 1 	 (S[dcl]\NP)/S[dcl] 	 2 	 expects said
6 	 3 	 ((S[dcl]\NP)/(S[ng]\NP))/NP 	 3 	 increase expects
6 	 4 	 NP[nb]/N 	 1 	 increase a
6 	 5 	 N/N 	 1 	 increase substantial
6 	 7 	 (NP\NP)/NP 	 1 	 increase in
6 	 10 	 (NP\NP)/NP 	 1 	 increase for
6 	 15 	 (S[ng]\NP)/NP 	 1 	 increase barring <XB>
9 	 7 	 (NP\NP)/NP 	 2 	 profit in
9 	 8 	 N/N 	 1 	 profit consolidated
13 	 10 	 (NP\NP)/NP 	 2 	 year for
13 	 11 	 NP[nb]/N 	 1 	 year the
13 	 12 	 N/N 	 1 	 year full
15 	 3 	 ((S[dcl]\NP)/(S[ng]\NP))/NP 	 2 	 barring expects
19 	 15 	 (S[ng]\NP)/NP 	 2 	 changes barring
19 	 16 	 N/N 	 1 	 changes major
19 	 17 	 N/N 	 1 	 changes currency
19 	 18 	 N/N 	 1 	 changes rate
<\s>
